US Stock MarketDetailed Quotes

SLS Sellas Life Sciences

Watchlist
  • 1.170
  • -0.020-1.68%
Close Nov 4 16:00 ET
  • 1.180
  • +0.010+0.85%
Post 17:26 ET
75.27MMarket Cap-1300P/E (TTM)

About Sellas Life Sciences Company

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Company Profile

SymbolSLS
Company NameSellas Life Sciences
Listing DateMar 12, 2008
Founded2006
CEODr. Angelos M. Stergiou, M.D.
MarketNASDAQ
Employees16
Fiscal Year Ends12-31
AddressTimes Square Tower,7 Times Square,Suite 2503
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10026
Phone1-646-200-5278
Websitehttp://www.sellaslifesciences.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Angelos M. Stergiou, M.D.
  • Director, President and Chief Executive Officer
  • 1.75M
  • John T. Burns, C.P.A.
  • Senior Vice President, Finance, Chief Financial Officer and Chief Accounting Officer
  • 783.11K
  • Jane Wasman, J.D.
  • Chairman of the Board
  • 136.28K
  • Katherine Bach Kalin, M.B.A.
  • Independent Director
  • 92.50K
  • John Varian
  • Independent Director
  • 110.50K
  • Robert L. Van Nostrand
  • Independent Director
  • 106.28K
  • Dr. David A. Scheinberg,M.D.,PhD
  • Independent Director
  • 102.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data